Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Dev Regulatory News (FDEV)

Share Price Information for Frontier Dev (FDEV)

Share Price is delayed by 15 minutes
Get Live Data
461.50    5.00 (1.10%)
Bid:
455.50
Ask:
460.00
Spread: 4.50 (0.988%)
Market Cap: £160.29m
FDEV Live PriceLast checked at - London Stock Exchange

Intraday Frontier Dev Share Chart

Trading Update

22 Apr 2015 07:00

RNS Number : 9117K
Frontier Developments PLC
22 April 2015
 



22 April 2015

Frontier Developments plc

Trading Update

Frontier Developments plc (AIM: FDEV, "Frontier", the "Group"), a leading developer of video games, announces the following trading update.

Elite: Dangerous 

The Board continues to be pleased with the progress of Elite: Dangerous to date. Total unit sales now exceed 500,000. The retail price remains £40 (US$60, €50).

The Group continues to add new platforms and distribution channels to further expand the audience. In addition to the forthcoming availability on Apple's Mac computers next month, and Microsoft's Xbox One games console later this year, Elite: Dangerous was recently made available on the Steam digital distribution service, entering at number 1 in their sales charts just before Easter.

Cash Position

The Group's balance sheet remains strong and, at 31 March 2015, the Group had net cash of approximately £11.4 million. This places the Group in a good financial position to support its continuing investment plans going forwards. As a result, the Group has reviewed its cash resource requirements for the next 12 months and decided to lower its revolving credit facility with Barclays Bank plc from £3m to £1m. This facility expires in May 2016.

David Braben, Chief Executive of Frontier Developments, said:

"The team did a great job in delivering the full public release of Elite: Dangerous and its supporting technology as planned, driving our transition to the next stage. We are and will continue to support it going forwards and that has helped build a great community around the game, setting us up well for future expansion. We, as a Board, are hopeful that sales will continue to track higher than we expected in the January Trading Update, leading to Group revenues of over £22 million by the end of the current financial year ending 31 May 2015."

Enquiries:

Frontier Developments

+44 (0)1223 394 300

David Braben, CEO

David Walsh, COO

Neil Armstrong, CFO

 

 

 

 

Canaccord Genuity

+44 (0) 207 523 8000

Simon Bridges/Cameron Duncan

 

 

 

 

Finncap

+44 (0) 207 220 0506

Charlotte Stranner

 

 

 

 

Tulchan Communications

+44 (0) 207 353 4200

James Macey White

 

 

 

About Frontier Developments plc 

Frontier Developments plc, listed on the AIM stock market (AIM: FDEV), is a leading independent game developer founded in 1994 by David Braben, co-author of the seminal 'Elite' game. Based in Cambridge, Frontier uses its proprietary 'Cobra' game development technology to create innovative games across videogame consoles, computers, smartphones and tablets.

The studio released Zoo Tycoon as a launch title for Microsoft's Xbox One console in 2013 and Tales from Deep Space for Amazon in 2014. It continues to work on ScreamRide for Microsoft and other unannounced titles in addition to expansion of Elite: Dangerous.

www.frontier.co.uk

Important Note

The information contained in this announcement about the sales of Elite: Dangerous relates solely to this game and does not constitute a profit estimate or profit forecast in respect of the Group or any guidance as to the likely profits of the Group. The scenarios contained in the announcement have been prepared by the directors based on their own industry knowledge and analysis and there are a number of factors which could or may cause the actual sales of the game and revenue generated from such sales to differ materially from those expressed or implied by such scenarios.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTIBMATMBATBIA
Date   Source Headline
1st Jun 202612:05 pmRNSEBT Share Purchase
28th May 20262:30 pmRNS-RPlanet Zoo 2 Announced
22nd May 202611:26 amRNS-RWarhammer 40,000: Chaos Gate – Deathwatch Revealed
22nd May 20269:16 amRNSHolding(s) in Company
19th May 20265:47 pmRNSHolding(s) in Company
18th May 202610:48 amRNSEBT Share Purchase
12th May 20267:00 amRNSTrading Update - FY26 Revenue & Profit Upgraded
23rd Apr 20267:00 amRNSCompletion of Share Buyback Programme
23rd Apr 20267:00 amRNSDirector/PDMR Shareholding
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 202611:05 amRNSHolding(s) in Company
22nd Apr 20267:00 amRNSDirector/PDMR Shareholding
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSDirector/PDMR Shareholding
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSDirector/PDMR Shareholding
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSDirector/PDMR Shareholding
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSDirector/PDMR Shareholding
14th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSDirector/PDMR Shareholding
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSDirector/PDMR Shareholding
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSDirector/PDMR Shareholding
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSDirector/PDMR Shareholding
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSDirector/PDMR Shareholding
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSDirector/PDMR Shareholding
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.